Local 12: Researcher working to help patients with tough-to-beat pancreatic cancer
Local 12 recently highlighted University of Cincinnati Cancer Center researcher Andrew Waters, PhD.
Waters specializes in pancreatic cancer research, and the National Cancer Institute recently announced an intent to fund research in his lab focused on treatments that target KRAS-mutated pancreatic cancer.
Waters said the KRAS gene is like a light switch. When mutated, it is left on and causes cells to divide and grow uncontrollably. The first line of drugs targeting KRAS has been approved for different cancers, but they target a mutation not often found in pancreatic cancer.
"A focus of my research lab and other labs and others around the country is really trying to use pre-clinical and clinical drugs that target the other 98-99 percent of pancreatic cancer patients," Waters told Local 12.
"The other main focus of my lab is really trying to address this relapse," he continued. "So, when KRAS drugs are available for pancreatic cancer patients, how are these cells going to be able to adapt? And how can we cut off those adaptation mechanisms with another FDA-approved drug?"
Watch the Local 12 story on Waters' research.
Waters was also featured in a Local 12 story about a woman raising money for pancreatic cancer research. Watch the story.
Read more about Waters' research.
Featured photo at top: Researchers Krushna Patra, Andrew Waters and Patrick Krause review data. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.